The Impact of Rockall Risk Scoring System on Management of Upper Gastrointestinal System Bleeding
1 other identifier
observational
100
1 country
1
Brief Summary
The patients who admit to emergency department with upper gastrointestinal system bleeding will undergo a clinical evaluation with Rockall Risk Scoring System. The patients with Rockall score of 1 or less will be discharged with medical treatment, and will have an elective upper gastrointestinal endoscopy in the end of the 30th day. The impact of Rockall Risk Scoring System on assessing the necessity of emergency endoscopy, length of hospital stay, morbidity, and mortality in low-risk patients will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 30, 2010
CompletedFirst Posted
Study publicly available on registry
January 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedOctober 17, 2012
October 1, 2012
2 years
December 30, 2010
October 16, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The necessity of emergency endoscopy.
1 month
Secondary Outcomes (3)
Morbidity
1 month
Mortality
1 month
Length of hospital stay
1 month
Study Arms (1)
Go-home group
The patients with a Rockall score of 0 or 1 will be prescribed medical therapy, and will be scheduled for elective gastroscopy.
Interventions
Eligibility Criteria
All patients older than 18 years with upper gastrointestinal hemorrhage.
You may qualify if:
- Clinical diagnosis of upper gastrointestinal system bleeding
- Rockall score of 1 or less
- Volunteers
- Agreement with the terms of informed consent
You may not qualify if:
- Uncertain clinical diagnosis of upper gastrointestinal system bleeding
- Rockall score of 2 or greater
- Deterioration in hemodynamic parameters during follow-up
- Unwilling patients to join the study
- Disagreement with the terms of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Sadi Konuk Training and Research Hospital
Istanbul, 34147, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Halil Alis, MD
Dr. Sadi Konuk Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
December 30, 2010
First Posted
January 4, 2011
Study Start
December 1, 2010
Primary Completion
December 1, 2012
Study Completion
March 1, 2013
Last Updated
October 17, 2012
Record last verified: 2012-10